BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9397426)

  • 1. Effects of divalproex sodium on 5-HT1A receptor function in healthy human males: hypothermic, hormonal, and behavioral responses to ipsapirone.
    Shiah IS; Yatham LN; Lam RW; Zis AP
    Neuropsychopharmacology; 1997 Dec; 17(6):382-90. PubMed ID: 9397426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls.
    Yatham LN; Shiah IS; Lam RW; Tam EM; Zis AP
    J Affect Disord; 1999 Aug; 54(3):295-301. PubMed ID: 10467974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.
    Delva NJ; Brooks DL; Franklin M; al-Said K; Hawken ER; Merali Z; Lawson JS; Ravindran AV
    J Psychiatry Neurosci; 2002 Nov; 27(6):429-37. PubMed ID: 12491576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects.
    Gelfin Y; Lerer B; Lesch KP; Gorfine M; Allolio B
    Psychopharmacology (Berl); 1995 Aug; 120(3):356-64. PubMed ID: 8524984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.
    Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ
    Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
    Cleare AJ; Forsling M; Bond AJ
    Int Clin Psychopharmacol; 1998 Jan; 13(1):23-32. PubMed ID: 9988364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol, hypothermic, and behavioral responses to ipsapirone in patients with bipolar depression and normal controls.
    Shiah IS; Yatham LN; Lam RW; Tam EM; Zis AP
    Neuropsychobiology; 1998; 38(1):6-12. PubMed ID: 9701716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects.
    Price LH; Cappiello A; Malison RT; McDougle CJ; Pelton GH; Schöllnhammer G; Heninger GR
    Neuropsychopharmacology; 1997 Oct; 17(4):246-57. PubMed ID: 9326749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge.
    Lerer B; Gelfin Y; Gorfine M; Allolio B; Lesch KP; Newman ME
    Neuropsychopharmacology; 1999 Jun; 20(6):628-39. PubMed ID: 10327431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
    Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder.
    Broocks A; Bandelow B; Koch K; Bartmann U; Kinkelbur J; Schweiger U; Hohagen F; Hajak G
    Neuropsychopharmacology; 2002 Aug; 27(2):270-8. PubMed ID: 12093600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression.
    Cleare AJ; Bond AJ
    Psychopharmacology (Berl); 2000 Mar; 148(4):344-9. PubMed ID: 10928305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lamotrigine on the 5-HT1A receptor function in healthy human males.
    Shiah IS; Yatham LN; Lam RW; Zis AP
    J Affect Disord; 1998 May; 49(2):157-62. PubMed ID: 9609681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with an anxiolytic dose of the 5-HT1A agonist ipsapirone does not alter ipsapirone acute neuroendocrine effects.
    Schmidt BH; Chaouloff F
    Psychoneuroendocrinology; 1993; 18(7):457-66. PubMed ID: 7903466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation.
    Blier P; Seletti B; Gilbert F; Young SN; Benkelfat C
    Neuropsychopharmacology; 2002 Aug; 27(2):301-8. PubMed ID: 12093604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats.
    Li Q; Brownfield MS; Levy AD; Battaglia G; Cabrera TM; Van de Kar LD
    Biol Psychiatry; 1994 Sep; 36(5):300-8. PubMed ID: 7993956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy.
    Shapira B; Newman ME; Gelfin Y; Lerer B
    Psychoneuroendocrinology; 2000 Jul; 25(5):421-38. PubMed ID: 10818278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted hormone responses to Ipsapirone are associated with trait impulsivity in personality disorder patients.
    Minzenberg MJ; Grossman R; New AS; Mitropoulou V; Yehuda R; Goodman M; Reynolds DA; Silverman JM; Coccaro EF; Marcus S; Siever LJ
    Neuropsychopharmacology; 2006 Jan; 31(1):197-203. PubMed ID: 16123761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder.
    Lesch KP; Hoh A; Schulte HM; Osterheider M; Müller T
    Psychopharmacology (Berl); 1991; 105(3):415-20. PubMed ID: 1686817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.